Dr. Amita Naithani, Leading Gynae Oncologist in Gurugram

Surgery for Cancer Ovary-HIPEC/HITHOC

Comprehensive Gynecologic Oncology Care for Women's Health

Overview
Surgery for ovarian cancer, particularly the innovative Hyperthermic Intraperitoneal Chemotherapy (HIPEC) or Hyperthermic Intrathoracic Chemotherapy (HITHOC), represents a groundbreaking approach. After debulking tumor masses, heated chemotherapy is directly circulated into the abdominal or thoracic cavities, targeting residual cancer cells. HIPEC ensures maximal drug absorption, enhancing treatment efficacy. This procedure is reserved for advanced cases, preventing cancer recurrence and improving survival rates. The technique minimizes systemic side effects while maximizing the concentration of chemotherapy at the tumor site. Although demanding, HIPEC/HITHOC showcases promising results, transforming ovarian cancer management and offering new hope in the quest for more effective treatments. Advances in surgical techniques continually refine this approach for enhanced outcomes.

Strategic Steps in Targeted Chemotherapy Delivery for Enhanced Efficacy

Debulking surgery: Tumor mass removal for optimal chemotherapy exposure
Circulation setup: Establishing closed-loop systems for drug delivery precision
Hyperthermia initiation: Elevating temperature to intensify chemotherapy impact on cancer cells
Chemotherapy infusion: Direct application into peritoneal or thoracic cavities for focused treatment
Postoperative monitoring: Close observation for potential complications and recovery assessment

Strategic Benefits of Hyperthermic Chemotherapy in Advanced Ovarian Cases

Localized treatment: Targets cancer cells directly, minimizing systemic exposure
Enhanced drug absorption: Maximized chemotherapy efficacy within the abdominal or thoracic cavities
Reduced side effects: Minimizes systemic toxicity associated with traditional chemotherapy
Improved survival rates: Elevates outcomes in advanced ovarian cancer cases
Prevention of recurrence: Reduces the likelihood of cancer regrowth after surgery

Strategic Knowledge for Progress in Treating and Advancing Women's Health

Informed decision-making: Enables patients to actively participate in treatment choices
Early intervention: Promotes timely access to advanced cancer therapies
Clinical trial participation: Enhances options for cutting-edge treatments and research
Reduced treatment hesitation: Mitigates fear, fostering proactive health-seeking behavior
Healthcare provider collaboration: Facilitates informed discussions and personalized treatment plans

Pioneering Women's Cancer Care: Excellence in Expertise and Innovation

A distinguished Gynae Oncology Consultant with extensive experience
Proficient in complex surgeries, including HIPEC, HITHOC, and robotic procedures
Certified DaVinci Robotic Console Surgeon, ensuring cutting-edge surgical capabilities
Over a decade as a Gynecologic Oncology Consultant at Rajiv Gandhi Cancer Institute
Contributions to gynecologic oncology research, earning accolades and awards

About Doctor

Dr. Amita Naithani

Gynae Oncologist